People across South Lanarkshire are being invited to have their say on a plan that will shape the ongoing development of local health and social care services.

 

South Lanarkshire Health and Social Care Partnership (H&SCP) are currently seeking views on their Strategic Commissioning Plan 2022 – 2025. In effect, the document will be a blueprint for the future – as it will set down key priorities to inform significant resources invested in health and social care provision going forward.

 

The partnership has just published an easy-to-use online survey – https://bit.ly/2Vhoonq – and is currently holding a range of targeted events with stakeholders.

 

Soumen Sengupta, Director of Health and Social Care for South Lanarkshire, stated: “Health and social care staff across South Lanarkshire are working tirelessly to address the significant challenges created by the ongoing Covid-19 pandemic.

 

“At the same time, I am also committed to looking to the future, collectively, and being ambitious for what we think our ‘new normal’ should look like.”

 

He added “We all have a role play in shaping a progressive and sustainable vision for health and social care services.”

 

Craig Cunningham, Head of Commissioning and Performance for the H&SCP, highlighted that gleaning feedback and hearing views is fundamental to planning for the future.

 

“In essence, the Strategic Commissioning Plan will focus on the support that the H&SCP can provide to people in local communities to assist them to maximise their health and wellbeing.

 

“So it’s vitally important we hear from individuals from across the communities of South Lanarkshire in terms of what matters to them and their families.”

 

The online survey is open until the end of November 2021.

 

 

SLHSCP TAKE OUR SURVEY.mp4 from NHS Lanarkshire on Vimeo.

Healthcare Professional ONLY
This website is intended for Healthcare professionals only

Are you a qualified pharmacist or health professional?
By continuing to access this site, you are consenting to viewing promotional product information provided by our pharmaceutical company sponsors